Free Trial

Astrana Health (NASDAQ:ASTH) Shares Acquired Rep. Judy Chu

Astrana Health logo with Medical background

Key Points

  • Representative Judy Chu purchased shares of Astrana Health, Inc. (NASDAQ:ASTH), investing between $100,001 and $250,000 on August 19th.
  • Astrana Health reported a 34.7% increase in quarterly revenue year-over-year, with revenue of $654.81 million, but missed earnings estimates with an EPS of $0.19.
  • Institutional investors hold over 52% of Astrana Health's stock, with significant stake increases from firms like Quarry LP and Covestor Ltd.
  • Interested in Astrana Health? Here are five stocks we like better.

Representative Judy Chu (D-California) recently bought shares of Astrana Health, Inc. NASDAQ: ASTH. In a filing disclosed on August 30th, the Representative disclosed that they had bought between $100,001 and $250,000 in Astrana Health stock on August 19th.

Representative Judy Chu also recently made the following trade(s):

  • Sold $100,001 - $250,000 in shares of Astrana Health NASDAQ: ASTH on 8/19/2025.

Astrana Health Stock Down 3.7%

Shares of Astrana Health stock traded down $1.18 during trading on Wednesday, reaching $30.70. The stock had a trading volume of 406,263 shares, compared to its average volume of 465,230. Astrana Health, Inc. has a 52 week low of $21.20 and a 52 week high of $63.20. The company has a market capitalization of $1.72 billion, a price-to-earnings ratio of 62.67, a P/E/G ratio of 0.79 and a beta of 0.85. The stock has a fifty day moving average price of $26.26 and a two-hundred day moving average price of $28.33. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. During the same period in the prior year, the company earned $0.40 earnings per share. The firm's revenue was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. Sell-side analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Zacks Research lowered shares of Astrana Health from a "strong-buy" rating to a "strong sell" rating in a report on Monday. Six research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $53.29.

Read Our Latest Stock Report on Astrana Health

Hedge Funds Weigh In On Astrana Health

A number of hedge funds have recently bought and sold shares of the business. Quarry LP grew its stake in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after acquiring an additional 471 shares during the period. Covestor Ltd increased its stake in Astrana Health by 777.6% in the first quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares during the period. Tower Research Capital LLC TRC lifted its holdings in shares of Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company's stock worth $115,000 after buying an additional 3,517 shares during the period. AlphaQuest LLC lifted its holdings in Astrana Health by 144.2% during the first quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock worth $151,000 after buying an additional 2,883 shares during the period. Finally, State of Wyoming acquired a new stake in Astrana Health in the second quarter valued at approximately $132,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

About Representative Chu

Judy Chu (Democratic Party) is a member of the U.S. House, representing California's 28th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. Chu (Democratic Party) is running for re-election to the U.S. House to represent California's 28th Congressional District. She declared candidacy for the 2026 election. Judy Chu was born in Los Angeles, California. Chu earned a B.A. from the University of California at Los Angeles in 1974 and a Ph.D. from the California School of Professional Psychology in 1979. Her career experience includes working as a professor with Los Angeles City College and East Los Angeles College. Chu served as the mayor of Monterey Park, California.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Should You Invest $1,000 in Astrana Health Right Now?

Before you consider Astrana Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.

While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.